Here are six key notes:
1. Elipse is the world’s first procedureless gastric balloon for weight loss.
2. It is made of thin, flexible polymer film and is delivered in a swallowable capsule.
3. This is the company’s first regulatory approval.
4. Elipse will initially be available in France, Italy and the United Kingdom.
5. Elipse is not yet approved by the FDA.
6. Allurion Technologies is focused on developing less invasive treatments for overweight and obese individuals.
More articles on GI/endoscopy:
4 GI physicians in the news – Dec. 4, 2015
FDA clears 5 GI/endoscopy devices in November
A day in the life: 24 statistics on how gastroenterologists spend their time
